Microdose Psychedelic Insights, a cutting-edge media company focused on promoting content, financial analysis and engaging events designed to drive the psychedelics industry into the forefront of modern medicine, will be hosting the upcoming Wonderland Miami Conference. The event, designed to provide attendees with insights into some of the top companies, latest IPOs, newest opportunities and most recent developments within the space, is slated to take place on Nov. 8-9, 2021, at Miami’s Adrienne Arsht Center for the Performing Arts. Microdose Psychedelic Insights has announced further details on the event’s agenda. According to the update, speakers will include Robin Carhart-Harris, the Ralph Metzner Distinguished Professor of Neurology and Psychiatry at University of California San Francisco; Prof David Nutt and Dr. Ben Sessa from Awakn Life Sciences; Dr. Matthew Johnson, Professor of Psychiatry and Behavioral Sciences at John Hopkins; and Rick Doblin, Ph.D. The conference will feature an in-depth discussion on the past, present and future of ketamine, engaging topics, such as accessibility as the key to unlocking the transformational power of psychedelic medicine, as well as a variety of fireside chats that delve into details, trends and new paradigms.
To view the full press release, visit https://ibn.fm/ImMUC
About Microdose Psychedelic Insights
Microdose Psychedelic Insights is your guide to the psychedelic medicine industry. With a vision to shift the world’s perception of psychedelic medicine, Microdose Psychedelic Insights distributes and creates the most compelling content, financial analysis, engaging events and ground-breaking education to drive the psychedelics industry to the forefront of modern medicine. Additional information about the Wonderland Miami Conference, including details for registration, can be found on the conference website at https://microdose.buzz/wonderland/miami.
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.